Table 2.
Adverse reactions at the application site | Tazarotene foam, n=744 | Vehicle foam, n=741 |
---|---|---|
Patients with any adverse reaction, n (%) | 163 (22) | 19 (3) |
Irritation | 107 (14) | 9 (1) |
Dryness | 50 (7) | 8 (1) |
Erythema | 48 (6) | 3 (<1) |
Exfoliation | 44 (6) | 3 (<1) |
Pain | 9 (1) | 0 |
Photosensitivity (including sunburn) | 8 (1) | 3 (<1) |
Pruritus | 7 (1) | 3 (<1) |
Dermatitis | 6 (1) | 1 (<1) |